StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd

<< Previous

Bullboard Posts

Next >>

Post by LithLoveron Nov 22, 2022 10:46am

130 Views

Post# 35118650

Five-year survival rates from an early-stage cancer diagnosis vs. a late-stage cancer diagnosis are significantly higher. A cancer diagnosis is scary, but it doesn’t have to be if you find it early.

The ARISTOTLE blood test is another way and can help detect multiple cancers from a single sample of blood through groundbreaking mRNA technology.

Learn more at https://ow.ly/OHtW50LHuPz

#EarlyMeansEverything #Liquid Biopsy
$SZLS, $SZLSF
No alternative text description for this image